ID CAC1E_HUMAN Reviewed; 2313 AA. AC Q15878; B1AM12; B1AM13; B1AM14; Q14580; Q14581; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 14-OCT-2008, sequence version 3. DT 27-MAR-2024, entry version 209. DE RecName: Full=Voltage-dependent R-type calcium channel subunit alpha-1E; DE AltName: Full=Brain calcium channel II; DE Short=BII; DE AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 6; DE AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.3; GN Name=CACNA1E; Synonyms=CACH6, CACNL1A6; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-1955. RC TISSUE=Brain; RX PubMed=7536609; RA Schneider T., Wei X., Olcese R., Costantin J.L., Neely A., Palade P., RA Perez-Reyes E., Qin N., Zhou J., Crawford G.D., Smith R.G., Appel S.H., RA Stefani E., Birnbaumer M.; RT "Molecular analysis and functional expression of the human type E neuronal RT Ca2+ channel alpha 1 subunit."; RL Recept. Channels 2:255-270(1994). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3). RC TISSUE=Hippocampus; RX PubMed=8071363; DOI=10.1016/s0021-9258(17)31796-9; RA Williams M.E., Marubio L.M., Deal C.R., Hans M., Brust P.F., RA Philipson L.H., Miller R.J., Johnson E.C., Harpold M.M., Ellis S.B.; RT "Structure and functional characterization of neuronal alpha 1E calcium RT channel subtypes."; RL J. Biol. Chem. 269:22347-22357(1994). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [4] RP INTERACTION WITH EFHC1. RX PubMed=15258581; DOI=10.1038/ng1393; RA Suzuki T., Delgado-Escueta A.V., Aguan K., Alonso M.E., Shi J., Hara Y., RA Nishida M., Numata T., Medina M.T., Takeuchi T., Morita R., Bai D., RA Ganesh S., Sugimoto Y., Inazawa J., Bailey J.N., Ochoa A., Jara-Prado A., RA Rasmussen A., Ramos-Peek J., Cordova S., Rubio-Donnadieu F., Inoue Y., RA Osawa M., Kaneko S., Oguni H., Mori Y., Yamakawa K.; RT "Mutations in EFHC1 cause juvenile myoclonic epilepsy."; RL Nat. Genet. 36:842-849(2004). RN [5] RP FUNCTION, INVOLVEMENT IN DEE69, VARIANTS DEE69 PRO-228; ARG-348; ARG-352; RP LEU-603; ASP-690; SER-698; THR-700; VAL-701; PRO-702; THR-702; RP 829-ARG--CYS-2313 DEL; 1389-ARG--CYS-2313 DEL; PHE-1422; ASN-1425; ARG-1430 RP AND GLY-1720, AND CHARACTERIZATION OF VARIANTS DEE69 LEU-603; SER-698; RP VAL-701 AND THR-702. RX PubMed=30343943; DOI=10.1016/j.ajhg.2018.09.006; RG Task Force for Neonatal Genomics; RG Deciphering Developmental Disorders Study; RA Helbig K.L., Lauerer R.J., Bahr J.C., Souza I.A., Myers C.T., Uysal B., RA Schwarz N., Gandini M.A., Huang S., Keren B., Mignot C., Afenjar A., RA Billette de Villemeur T., Heron D., Nava C., Valence S., Buratti J., RA Fagerberg C.R., Soerensen K.P., Kibaek M., Kamsteeg E.J., Koolen D.A., RA Gunning B., Schelhaas H.J., Kruer M.C., Fox J., Bakhtiari S., Jarrar R., RA Padilla-Lopez S., Lindstrom K., Jin S.C., Zeng X., Bilguvar K., RA Papavasileiou A., Xing Q., Zhu C., Boysen K., Vairo F., Lanpher B.C., RA Klee E.W., Tillema J.M., Payne E.T., Cousin M.A., Kruisselbrink T.M., RA Wick M.J., Baker J., Haan E., Smith N., Sadeghpour A., Davis E.E., RA Katsanis N., Corbett M.A., MacLennan A.H., Gecz J., Biskup S., Goldmann E., RA Rodan L.H., Kichula E., Segal E., Jackson K.E., Asamoah A., Dimmock D., RA McCarrier J., Botto L.D., Filloux F., Tvrdik T., Cascino G.D., RA Klingerman S., Neumann C., Wang R., Jacobsen J.C., Nolan M.A., Snell R.G., RA Lehnert K., Sadleir L.G., Anderlid B.M., Kvarnung M., Guerrini R., RA Friez M.J., Lyons M.J., Leonhard J., Kringlen G., Casas K., El Achkar C.M., RA Smith L.A., Rotenberg A., Poduri A., Sanchis-Juan A., Carss K.J., RA Rankin J., Zeman A., Raymond F.L., Blyth M., Kerr B., Ruiz K., Urquhart J., RA Hughes I., Banka S., Hedrich U.B.S., Scheffer I.E., Helbig I., RA Zamponi G.W., Lerche H., Mefford H.C.; RT "De novo pathogenic variants in CACNA1E cause developmental and epileptic RT encephalopathy with contractures, macrocephaly, and dyskinesias."; RL Am. J. Hum. Genet. 103:666-678(2018). RN [6] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1867-1885. RX PubMed=18400181; DOI=10.1016/j.str.2008.01.011; RA Mori M.X., Vander Kooi C.W., Leahy D.J., Yue D.T.; RT "Crystal structure of the CaV2 IQ domain in complex with Ca2+/calmodulin: RT high-resolution mechanistic implications for channel regulation by Ca2+."; RL Structure 16:607-620(2008). CC -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry CC of calcium ions into excitable cells (PubMed:30343943). They are also CC involved in a variety of calcium-dependent processes, including muscle CC contraction, hormone or neurotransmitter release, gene expression, cell CC motility, cell division and cell death. The isoform alpha-1E gives rise CC to R-type calcium currents. R-type calcium channels belong to the CC 'high-voltage activated' (HVA) group and are blocked by nickel. They CC are however insensitive to dihydropyridines (DHP). Calcium channels CC containing alpha-1E subunit could be involved in the modulation of CC firing patterns of neurons which is important for information CC processing. {ECO:0000269|PubMed:30343943}. CC -!- SUBUNIT: Interacts with EFHC1. Voltage-dependent calcium channels are CC multisubunit complexes, consisting of alpha-1, alpha-2, beta and delta CC subunits in a 1:1:1:1 ratio. The channel activity is directed by the CC pore-forming and voltage-sensitive alpha-1 subunit. In many cases, this CC subunit is sufficient to generate voltage-sensitive calcium channel CC activity. The auxiliary subunits beta and alpha-2/delta linked by a CC disulfide bridge regulate the channel activity. CC {ECO:0000269|PubMed:15258581}. CC -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; Synonyms=Alpha-1E; CC IsoId=Q15878-1; Sequence=Displayed; CC Name=2; Synonyms=Alpha-1E-1; CC IsoId=Q15878-2; Sequence=VSP_000937, VSP_024817; CC Name=3; Synonyms=Alpha-1E-3; CC IsoId=Q15878-3; Sequence=VSP_024817; CC -!- TISSUE SPECIFICITY: Expressed in neuronal tissues and in kidney. CC -!- DOMAIN: Each of the four internal repeats contains five hydrophobic CC transmembrane segments (S1, S2, S3, S5, S6) and one positively charged CC transmembrane segment (S4). S4 segments probably represent the voltage- CC sensor and are characterized by a series of positively charged amino CC acids at every third position. CC -!- DISEASE: Developmental and epileptic encephalopathy 69 (DEE69) CC [MIM:618285]: A form of epileptic encephalopathy, a heterogeneous group CC of severe early-onset epilepsies characterized by refractory seizures, CC neurodevelopmental impairment, and poor prognosis. Development is CC normal prior to seizure onset, after which cognitive and motor delays CC become apparent. DEE69 is an autosomal dominant form characterized by CC refractory seizures, hypotonia, and profoundly impaired development CC often associated with macrocephaly, hyperkinetic movements, and CC contractures. The disorder can sometimes result in early death. Some CC patients may have a favorable seizure response to topiramate CC medication. {ECO:0000269|PubMed:30343943}. Note=The disease is caused CC by variants affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit CC (TC 1.A.1.11) family. CACNA1E subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L27745; AAA72125.1; -; mRNA. DR EMBL; L29384; AAA59204.1; -; mRNA. DR EMBL; L29385; AAA59205.1; -; mRNA. DR EMBL; AL161734; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL359270; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL160059; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL590998; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS53443.1; -. [Q15878-3] DR CCDS; CCDS55664.1; -. [Q15878-1] DR CCDS; CCDS55665.1; -. [Q15878-2] DR PIR; A54972; A54972. DR PIR; B54972; B54972. DR RefSeq; NP_000712.2; NM_000721.3. [Q15878-3] DR RefSeq; NP_001192222.1; NM_001205293.1. [Q15878-1] DR RefSeq; NP_001192223.1; NM_001205294.1. [Q15878-2] DR PDB; 3BXL; X-ray; 2.30 A; B=1867-1887. DR PDB; 7XLQ; EM; 3.10 A; A=1-2313. DR PDB; 7YG5; EM; 3.00 A; A=1-2313. DR PDB; 8EPL; EM; 3.10 A; A=1-2313. DR PDB; 8EPM; EM; 3.10 A; A=1-2313. DR PDBsum; 3BXL; -. DR PDBsum; 7XLQ; -. DR PDBsum; 7YG5; -. DR PDBsum; 8EPL; -. DR PDBsum; 8EPM; -. DR AlphaFoldDB; Q15878; -. DR EMDB; EMD-28529; -. DR EMDB; EMD-28530; -. DR EMDB; EMD-33285; -. DR EMDB; EMD-33808; -. DR SMR; Q15878; -. DR BioGRID; 107231; 4. DR IntAct; Q15878; 1. DR STRING; 9606.ENSP00000356545; -. DR BindingDB; Q15878; -. DR ChEMBL; CHEMBL1687682; -. DR DrugBank; DB13746; Bioallethrin. DR DrugBank; DB11148; Butamben. DR DrugBank; DB11093; Calcium citrate. DR DrugBank; DB11348; Calcium Phosphate. DR DrugBank; DB14481; Calcium phosphate dihydrate. DR DrugBank; DB09235; Efonidipine. DR DrugBank; DB00228; Enflurane. DR DrugBank; DB00153; Ergocalciferol. DR DrugBank; DB00555; Lamotrigine. DR DrugBank; DB00622; Nicardipine. DR DrugBank; DB00421; Spironolactone. DR DrugBank; DB00273; Topiramate. DR DrugBank; DB00661; Verapamil. DR GuidetoPHARMACOLOGY; 534; -. DR GlyCosmos; Q15878; 3 sites, No reported glycans. DR GlyGen; Q15878; 3 sites. DR iPTMnet; Q15878; -. DR PhosphoSitePlus; Q15878; -. DR BioMuta; CACNA1E; -. DR DMDM; 209572758; -. DR EPD; Q15878; -. DR jPOST; Q15878; -. DR MassIVE; Q15878; -. DR MaxQB; Q15878; -. DR PaxDb; 9606-ENSP00000356545; -. DR PeptideAtlas; Q15878; -. DR ProteomicsDB; 60800; -. [Q15878-1] DR ProteomicsDB; 60801; -. [Q15878-2] DR ProteomicsDB; 60802; -. [Q15878-3] DR Antibodypedia; 34433; 143 antibodies from 20 providers. DR DNASU; 777; -. DR Ensembl; ENST00000367570.6; ENSP00000356542.1; ENSG00000198216.14. [Q15878-3] DR Ensembl; ENST00000367573.7; ENSP00000356545.2; ENSG00000198216.14. [Q15878-1] DR Ensembl; ENST00000621791.4; ENSP00000481619.1; ENSG00000198216.14. [Q15878-2] DR GeneID; 777; -. DR KEGG; hsa:777; -. DR MANE-Select; ENST00000367573.7; ENSP00000356545.2; NM_001205293.3; NP_001192222.1. DR UCSC; uc001gow.5; human. [Q15878-1] DR AGR; HGNC:1392; -. DR CTD; 777; -. DR DisGeNET; 777; -. DR GeneCards; CACNA1E; -. DR HGNC; HGNC:1392; CACNA1E. DR HPA; ENSG00000198216; Tissue enriched (brain). DR MalaCards; CACNA1E; -. DR MIM; 601013; gene. DR MIM; 618285; phenotype. DR neXtProt; NX_Q15878; -. DR OpenTargets; ENSG00000198216; -. DR PharmGKB; PA26009; -. DR VEuPathDB; HostDB:ENSG00000198216; -. DR eggNOG; KOG2301; Eukaryota. DR GeneTree; ENSGT00940000155601; -. DR HOGENOM; CLU_000540_1_0_1; -. DR InParanoid; Q15878; -. DR OMA; XRERRRR; -. DR OrthoDB; 1110761at2759; -. DR PhylomeDB; Q15878; -. DR TreeFam; TF312805; -. DR PathwayCommons; Q15878; -. DR Reactome; R-HSA-112308; Presynaptic depolarization and calcium channel opening. DR Reactome; R-HSA-422356; Regulation of insulin secretion. DR SignaLink; Q15878; -. DR SIGNOR; Q15878; -. DR BioGRID-ORCS; 777; 11 hits in 1138 CRISPR screens. DR ChiTaRS; CACNA1E; human. DR EvolutionaryTrace; Q15878; -. DR GeneWiki; R-type_calcium_channel; -. DR GenomeRNAi; 777; -. DR Pharos; Q15878; Tchem. DR PRO; PR:Q15878; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; Q15878; Protein. DR Bgee; ENSG00000198216; Expressed in middle temporal gyrus and 119 other cell types or tissues. DR ExpressionAtlas; Q15878; baseline and differential. DR GO; GO:0043025; C:neuronal cell body; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0045202; C:synapse; IEA:GOC. DR GO; GO:0005891; C:voltage-gated calcium channel complex; IBA:GO_Central. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0008331; F:high voltage-gated calcium channel activity; IBA:GO_Central. DR GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:MGI. DR GO; GO:0022843; F:voltage-gated monoatomic cation channel activity; IDA:UniProtKB. DR GO; GO:0098703; P:calcium ion import across plasma membrane; IBA:GO_Central. DR GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central. DR Gene3D; 1.10.287.70; -; 4. DR Gene3D; 6.10.250.2180; -; 1. DR Gene3D; 6.10.250.2500; -; 1. DR Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4. DR InterPro; IPR002048; EF_hand_dom. DR InterPro; IPR031649; GPHH_dom. DR InterPro; IPR005821; Ion_trans_dom. DR InterPro; IPR014873; VDCC_a1su_IQ. DR InterPro; IPR005449; VDCC_R_a1su. DR InterPro; IPR002077; VDCCAlpha1. DR InterPro; IPR027359; Volt_channel_dom_sf. DR PANTHER; PTHR45628; VOLTAGE-DEPENDENT CALCIUM CHANNEL TYPE A SUBUNIT ALPHA-1; 1. DR PANTHER; PTHR45628:SF5; VOLTAGE-DEPENDENT R-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1E; 1. DR Pfam; PF08763; Ca_chan_IQ; 1. DR Pfam; PF16905; GPHH; 1. DR Pfam; PF00520; Ion_trans; 4. DR PRINTS; PR00167; CACHANNEL. DR PRINTS; PR01633; RVDCCALPHA1. DR SMART; SM01062; Ca_chan_IQ; 1. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 4. DR PROSITE; PS50222; EF_HAND_2; 1. DR Genevisible; Q15878; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Calcium; Calcium channel; KW Calcium transport; Disease variant; Disulfide bond; Epilepsy; Glycoprotein; KW Ion channel; Ion transport; Membrane; Metal-binding; Phosphoprotein; KW Reference proteome; Repeat; Transmembrane; Transmembrane helix; Transport; KW Voltage-gated channel. FT CHAIN 1..2313 FT /note="Voltage-dependent R-type calcium channel subunit FT alpha-1E" FT /id="PRO_0000053938" FT TOPO_DOM 1..89 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 90..108 FT /note="Helical; Name=S1 of repeat I" FT TOPO_DOM 109..127 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 128..146 FT /note="Helical; Name=S2 of repeat I" FT TOPO_DOM 147..158 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 159..173 FT /note="Helical; Name=S3 of repeat I" FT TOPO_DOM 174..185 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 186..205 FT /note="Helical; Name=S4 of repeat I" FT TOPO_DOM 206..223 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 224..244 FT /note="Helical; Name=S5 of repeat I" FT TOPO_DOM 245..326 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 327..350 FT /note="Helical; Name=S6 of repeat I" FT TOPO_DOM 351..476 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 477..496 FT /note="Helical; Name=S1 of repeat II" FT TOPO_DOM 497..509 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 510..529 FT /note="Helical; Name=S2 of repeat II" FT TOPO_DOM 530..538 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 539..557 FT /note="Helical; Name=S3 of repeat II" FT TOPO_DOM 558..567 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 568..586 FT /note="Helical; Name=S4 of repeat II" FT TOPO_DOM 587..605 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 606..625 FT /note="Helical; Name=S5 of repeat II" FT TOPO_DOM 626..678 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 679..703 FT /note="Helical; Name=S6 of repeat II" FT TOPO_DOM 704..1148 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1149..1165 FT /note="Helical; Name=S1 of repeat III" FT TOPO_DOM 1166..1189 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1190..1209 FT /note="Helical; Name=S2 of repeat III" FT TOPO_DOM 1210..1217 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1218..1240 FT /note="Helical; Name=S3 of repeat III" FT TOPO_DOM 1241..1254 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1255..1272 FT /note="Helical; Name=S4 of repeat III" FT TOPO_DOM 1273..1291 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1292..1311 FT /note="Helical; Name=S5 of repeat III" FT TOPO_DOM 1312..1398 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1399..1422 FT /note="Helical; Name=S6 of repeat III" FT TOPO_DOM 1423..1479 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1480..1498 FT /note="Helical; Name=S1 of repeat IV" FT TOPO_DOM 1499..1513 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1514..1533 FT /note="Helical; Name=S2 of repeat IV" FT TOPO_DOM 1534..1541 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1542..1560 FT /note="Helical; Name=S3 of repeat IV" FT TOPO_DOM 1561..1571 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1572..1590 FT /note="Helical; Name=S4 of repeat IV" FT TOPO_DOM 1591..1609 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1610..1629 FT /note="Helical; Name=S5 of repeat IV" FT TOPO_DOM 1630..1698 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1699..1724 FT /note="Helical; Name=S6 of repeat IV" FT TOPO_DOM 1725..2313 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REPEAT 76..354 FT /note="I" FT REPEAT 462..706 FT /note="II" FT REPEAT 1140..1426 FT /note="III" FT REPEAT 1463..1726 FT /note="IV" FT DOMAIN 1739..1774 FT /note="EF-hand" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT REGION 1..38 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 374..391 FT /note="Binding to the beta subunit" FT /evidence="ECO:0000250" FT REGION 729..774 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 851..984 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1103..1125 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1970..2170 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2206..2225 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2263..2295 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 17..31 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 745..765 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 950..982 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1970..1996 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2005..2019 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2020..2034 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2065..2122 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2123..2156 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 426 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000305" FT BINDING 428 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000305" FT BINDING 430 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000305" FT BINDING 432 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000305" FT BINDING 1752 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000305" FT BINDING 1758 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000305" FT BINDING 1763 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000305" FT SITE 309 FT /note="Calcium ion selectivity and permeability" FT /evidence="ECO:0000250" FT SITE 657 FT /note="Calcium ion selectivity and permeability" FT /evidence="ECO:0000250" FT SITE 1372 FT /note="Calcium ion selectivity and permeability" FT /evidence="ECO:0000250" FT SITE 1663 FT /note="Calcium ion selectivity and permeability" FT /evidence="ECO:0000250" FT MOD_RES 14 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q61290" FT MOD_RES 19 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q61290" FT MOD_RES 427 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q61290" FT MOD_RES 440 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q61290" FT MOD_RES 736 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q07652" FT MOD_RES 745 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q61290" FT MOD_RES 793 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q07652" FT MOD_RES 815 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q61290" FT MOD_RES 855 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q61290" FT MOD_RES 947 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q07652" FT MOD_RES 1097 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q07652" FT MOD_RES 2094 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q61290" FT MOD_RES 2113 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q07652" FT CARBOHYD 254 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1566 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1571 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 748..766 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:8071363" FT /id="VSP_000937" FT VAR_SEQ 1967..2009 FT /note="Missing (in isoform 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:8071363" FT /id="VSP_024817" FT VARIANT 228 FT /note="L -> P (in DEE69; dbSNP:rs1553286282)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081838" FT VARIANT 348 FT /note="G -> R (in DEE69)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081839" FT VARIANT 352 FT /note="G -> R (in DEE69; dbSNP:rs886039323)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081840" FT VARIANT 603 FT /note="I -> L (in DEE69; gain-of-function variant affecting FT channel activity; results in hyperpolarizing shift in half FT activation voltage; dbSNP:rs778291283)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081841" FT VARIANT 690 FT /note="G -> D (in DEE69; dbSNP:rs1361083258)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081842" FT VARIANT 698 FT /note="F -> S (in DEE69; gain-of-function variant affecting FT channel activity; shifts the voltage dependence of FT activation toward more negative potentials and slows the FT fast inactivation time course; dbSNP:rs869312920)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081843" FT VARIANT 700 FT /note="A -> T (in DEE69)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081844" FT VARIANT 701 FT /note="I -> V (in DEE69; gain-of-function variant affecting FT channel activity; shifts the voltage dependence of FT activation toward more negative potentials and slows the FT fast inactivation time course; dbSNP:rs1558308998)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081845" FT VARIANT 702 FT /note="A -> P (in DEE69; dbSNP:rs12131800)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081846" FT VARIANT 702 FT /note="A -> T (in DEE69; gain-of-function variant affecting FT channel activity; shifts the voltage dependence of FT activation toward more negative potentials and slows the FT fast inactivation time course; dbSNP:rs12131800)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081847" FT VARIANT 829..2313 FT /note="Missing (in DEE69; uncertain significance)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081848" FT VARIANT 859 FT /note="D -> E (in dbSNP:rs35737760)" FT /id="VAR_031912" FT VARIANT 1389..2313 FT /note="Missing (in DEE69; uncertain significance)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081849" FT VARIANT 1422 FT /note="I -> F (in DEE69)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081850" FT VARIANT 1425 FT /note="T -> N (in DEE69)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081851" FT VARIANT 1430 FT /note="G -> R (in DEE69; dbSNP:rs1553345844)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081852" FT VARIANT 1720 FT /note="A -> G (in DEE69)" FT /evidence="ECO:0000269|PubMed:30343943" FT /id="VAR_081853" FT VARIANT 1955 FT /note="A -> T (in dbSNP:rs704326)" FT /evidence="ECO:0000269|PubMed:7536609" FT /id="VAR_046996" FT CONFLICT 648 FT /note="M -> I (in Ref. 1; AAA72125)" FT /evidence="ECO:0000305" FT CONFLICT 836..838 FT /note="LAL -> WP (in Ref. 1; AAA72125)" FT /evidence="ECO:0000305" FT CONFLICT 2077 FT /note="R -> P (in Ref. 2; AAA59204/AAA59205)" FT /evidence="ECO:0000305" FT CONFLICT 2084 FT /note="G -> R (in Ref. 2; AAA59204/AAA59205)" FT /evidence="ECO:0000305" FT CONFLICT 2206 FT /note="C -> W (in Ref. 2; AAA59204/AAA59205)" FT /evidence="ECO:0000305" FT CONFLICT 2219 FT /note="S -> R (in Ref. 2; AAA59204/AAA59205)" FT /evidence="ECO:0000305" FT CONFLICT 2245 FT /note="G -> V (in Ref. 2; AAA59204/AAA59205)" FT /evidence="ECO:0000305" FT HELIX 84..86 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 89..92 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 95..108 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 113..115 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 119..124 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 128..145 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 146..151 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 155..157 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 159..174 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 177..182 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 187..190 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 193..195 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 196..198 FT /evidence="ECO:0007829|PDB:8EPM" FT HELIX 199..203 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 205..217 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 219..223 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 224..243 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 249..254 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 256..258 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 269..271 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 274..281 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 285..288 FT /evidence="ECO:0007829|PDB:8EPM" FT STRAND 293..295 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 298..306 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 311..320 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 324..327 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 328..338 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 340..358 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 361..385 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 461..472 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 476..482 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 483..488 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 489..492 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 502..525 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 526..530 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 536..538 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 539..559 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 570..582 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 586..598 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 601..603 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 604..607 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 608..611 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 612..625 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 640..642 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 643..654 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 655..658 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 659..668 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 671..674 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 678..680 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 682..688 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 689..692 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 693..711 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 714..720 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 721..723 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 724..727 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 777..784 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1145..1147 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1148..1151 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1155..1166 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1168..1171 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1178..1180 FT /evidence="ECO:0007829|PDB:8EPL" FT HELIX 1181..1206 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1223..1242 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1251..1257 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1258..1267 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1268..1271 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1273..1275 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1276..1286 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1287..1290 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1295..1306 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1308..1311 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1312..1314 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1316..1320 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1326..1328 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1331..1335 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1337..1339 FT /evidence="ECO:0007829|PDB:8EPL" FT STRAND 1342..1345 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1348..1350 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1358..1369 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1375..1382 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1393..1396 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1397..1400 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1402..1409 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1410..1412 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1413..1424 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1434..1437 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1442..1446 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1468..1475 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1476..1484 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1487..1490 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1491..1496 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1506..1525 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1526..1528 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1529..1532 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1534..1537 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1540..1543 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1544..1559 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1561..1564 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1568..1570 FT /evidence="ECO:0007829|PDB:8EPL" FT HELIX 1572..1575 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1576..1579 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1580..1583 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1584..1589 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1593..1602 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1603..1605 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1610..1629 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1638..1640 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1642..1644 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1646..1648 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1649..1660 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1667..1670 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1673..1675 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1682..1684 FT /evidence="ECO:0007829|PDB:8EPL" FT STRAND 1688..1690 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1699..1722 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1723..1725 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1726..1729 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1733..1735 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1738..1740 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1742..1752 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1753..1755 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1763..1770 FT /evidence="ECO:0007829|PDB:7XLQ" FT TURN 1773..1775 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1784..1792 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1796..1798 FT /evidence="ECO:0007829|PDB:8EPL" FT HELIX 1805..1816 FT /evidence="ECO:0007829|PDB:7XLQ" FT STRAND 1823..1825 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1826..1842 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1848..1854 FT /evidence="ECO:0007829|PDB:7XLQ" FT HELIX 1868..1882 FT /evidence="ECO:0007829|PDB:3BXL" SQ SEQUENCE 2313 AA; 261731 MW; CCC7F309C27C42F1 CRC64; MARFGEAVVA RPGSGDGDSD QSRNRQGTPV PASGQAAAYK QTKAQRARTM ALYNPIPVRQ NCFTVNRSLF IFGEDNIVRK YAKKLIDWPP FEYMILATII ANCIVLALEQ HLPEDDKTPM SRRLEKTEPY FIGIFCFEAG IKIVALGFIF HKGSYLRNGW NVMDFIVVLS GILATAGTHF NTHVDLRTLR AVRVLRPLKL VSGIPSLQIV LKSIMKAMVP LLQIGLLLFF AILMFAIIGL EFYSGKLHRA CFMNNSGILE GFDPPHPCGV QGCPAGYECK DWIGPNDGIT QFDNILFAVL TVFQCITMEG WTTVLYNTND ALGATWNWLY FIPLIIIGSF FVLNLVLGVL SGEFAKERER VENRRAFMKL RRQQQIEREL NGYRAWIDKA EEVMLAEENK NAGTSALEVL RRATIKRSRT EAMTRDSSDE HCVDISSVGT PLARASIKSA KVDGVSYFRH KERLLRISIR HMVKSQVFYW IVLSLVALNT ACVAIVHHNQ PQWLTHLLYY AEFLFLGLFL LEMSLKMYGM GPRLYFHSSF NCFDFGVTVG SIFEVVWAIF RPGTSFGISV LRALRLLRIF KITKYWASLR NLVVSLMSSM KSIISLLFLL FLFIVVFALL GMQLFGGRFN FNDGTPSANF DTFPAAIMTV FQILTGEDWN EVMYNGIRSQ GGVSSGMWSA IYFIVLTLFG NYTLLNVFLA IAVDNLANAQ ELTKDEQEEE EAFNQKHALQ KAKEVSPMSA PNMPSIERDR RRRHHMSMWE PRSSHLRERR RRHHMSVWEQ RTSQLRKHMQ MSSQEALNRE EAPTMNPLNP LNPLSSLNPL NAHPSLYRRP RAIEGLALGL ALEKFEEERI SRGGSLKGDG GDRSSALDNQ RTPLSLGQRE PPWLARPCHG NCDPTQQEAG GGEAVVTFED RARHRQSQRR SRHRRVRTEG KESSSASRSR SASQERSLDE AMPTEGEKDH ELRGNHGAKE PTIQEERAQD LRRTNSLMVS RGSGLAGGLD EADTPLVLPH PELEVGKHVV LTEQEPEGSS EQALLGNVQL DMGRVISQSE PDLSCITANT DKATTESTSV TVAIPDVDPL VDSTVVHISN KTDGEASPLK EAEIREDEEE VEKKKQKKEK RETGKAMVPH SSMFIFSTTN PIRRACHYIV NLRYFEMCIL LVIAASSIAL AAEDPVLTNS ERNKVLRYFD YVFTGVFTFE MVIKMIDQGL ILQDGSYFRD LWNILDFVVV VGALVAFALA NALGTNKGRD IKTIKSLRVL RVLRPLKTIK RLPKLKAVFD CVVTSLKNVF NILIVYKLFM FIFAVIAVQL FKGKFFYCTD SSKDTEKECI GNYVDHEKNK MEVKGREWKR HEFHYDNIIW ALLTLFTVST GEGWPQVLQH SVDVTEEDRG PSRSNRMEMS IFYVVYFVVF PFFFVNIFVA LIIITFQEQG DKMMEECSLE KNERACIDFA ISAKPLTRYM PQNRHTFQYR VWHFVVSPSF EYTIMAMIAL NTVVLMMKYY SAPCTYELAL KYLNIAFTMV FSLECVLKVI AFGFLNYFRD TWNIFDFITV IGSITEIILT DSKLVNTSGF NMSFLKLFRA ARLIKLLRQG YTIRILLWTF VQSFKALPYV CLLIAMLFFI YAIIGMQVFG NIKLDEESHI NRHNNFRSFF GSLMLLFRSA TGEAWQEIML SCLGEKGCEP DTTAPSGQNE NERCGTDLAY VYFVSFIFFC SFLMLNLFVA VIMDNFEYLT RDSSILGPHH LDEFVRVWAE YDRAACGRIH YTEMYEMLTL MSPPLGLGKR CPSKVAYKRL VLMNMPVAED MTVHFTSTLM ALIRTALDIK IAKGGADRQQ LDSELQKETL AIWPHLSQKM LDLLVPMPKA SDLTVGKIYA AMMIMDYYKQ SKVKKQRQQL EEQKNAPMFQ RMEPSSLPQE IIANAKALPY LQQDPVSGLS GRSGYPSMSP LSPQDIFQLA CMDPADDGQF QERQSLEPEV SELKSVQPSN HGIYLPSDTQ EHAGSGRASS MPRLTVDPQV VTDPSSMRRS FSTIRDKRSN SSWLEEFSME RSSENTYKSR RRSYHSSLRL SAHRLNSDSG HKSDTHRSGG RERGRSKERK HLLSPDVSRC NSEERGTQAD WESPERRQSR SPSEGRSQTP NRQGTGSLSE SSIPSVSDTS TPRRSRRQLP PVPPKPRPLL SYSSLIRHAG SISPPADGSE EGSPLTSQAL ESNNACLTES SNSPHPQQSQ HASPQRYISE PYLALHEDSH ASDCGEEETL TFEAAVATSL GRSNTIGSAP PLRHSWQMPN GHYRRRRRGG PGPGMMCGAV NNLLSDTEED DKC //